Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) EBT: 2023-2024

Historic EBT for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to -$65.4 million.

  • Artiva Biotherapeutics' EBT fell 41.30% to -$16.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$61.9 million, marking a year-over-year change of. This contributed to the annual value of -$65.4 million for FY2024, which is 128.19% down from last year.
  • According to the latest figures from FY2024, Artiva Biotherapeutics' EBT is -$65.4 million, which was down 128.19% from -$28.6 million recorded in FY2023.
  • In the past 5 years, Artiva Biotherapeutics' EBT ranged from a high of -$28.6 million in FY2023 and a low of -$65.4 million during FY2024.
  • Its 2-year average for EBT is -$47.0 million, with a median of -$47.0 million in 2023.
  • Data for Artiva Biotherapeutics' EBT shows a maximum YoY plummeted of 128.19% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Artiva Biotherapeutics' EBT stood at -$28.6 million in 2023, then crashed by 128.19% to -$65.4 million in 2024.